Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
15
×
detroit blog main
15
×
detroit top stories
national blog main
national top stories
new york blog main
raleigh-durham blog main
san francisco blog main
startups
15
×
wisconsin blog main
biotech
boston blog main
life sciences
new york top stories
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
national
deals
fda
clinical trials
eli lilly
cancer immunotherapy
alzheimer's disease
investing
takeda pharmaceutical
abbvie
biogen
ipo
What
roundup
bio
drug
companies
week
drugs
fda
life
new
pharmaceutical
sciences
acquisitions
ahead
alzheimer’s
annual
asco
attention
biotech
black
buy
cancer
cash
ceo
covid
daniel
days
debut
diamond’s
gilead
growing
ipo
medicines
merck
moves
nash
news
oncology
oncology’s
o’day
price
Language
unset
Current search:
startups
×
cancer
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round